Instil Bio Capital Expenditures (CapEx) Growth & History (TIL)
Instil Bio's capital expenditures (capex) was $10.0M for fiscal 2025.
View full Instil Bio company overviewInstil Bio annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $10.0M | $10.0M | — |
| 2024 | 2024-12-31 | $0 | −$20.7M | — |
| 2023 | 2023-12-31 | $20.7M | −$63.9M | −75.57% |
| 2022 | 2022-12-31 | $84.6M | $26.8M | +46.27% |
| 2021 | 2021-12-31 | $57.8M | $7.0M | +13.80% |
| 2020 | 2020-12-31 | $50.8M | — | — |
Instil Bio quarterly capital expenditures (capex)
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | $0 | −$58,000 | — |
| Q3 2024 | 2024-09-30 | $0 | −$5.2M | — |
| Q2 2024 | 2024-06-30 | $0 | −$7.0M | — |
| Q1 2024 | 2024-03-31 | $0 | −$8.5M | — |
| Q4 2023 | 2023-12-31 | $58,000 | −$13.0M | −99.55% |
| Q3 2023 | 2023-09-30 | $5.2M | −$20.0M | −79.53% |
| Q2 2023 | 2023-06-30 | $7.0M | −$19.2M | −73.30% |
| Q1 2023 | 2023-03-31 | $8.5M | −$11.8M | −58.16% |
| Q4 2022 | 2022-12-31 | $13.0M | −$5.5M | −29.53% |
| Q3 2022 | 2022-09-30 | $25.2M | $3.5M | +15.88% |
| Q2 2022 | 2022-06-30 | $26.1M | $17.6M | +207.82% |
| Q1 2022 | 2022-03-31 | $20.2M | $11.1M | +121.66% |
| Q4 2021 | 2021-12-31 | $18.5M | −$26.8M | −59.21% |
| Q3 2021 | 2021-09-30 | $21.7M | $17.4M | +405.46% |
| Q2 2021 | 2021-06-30 | $8.5M | $8.2M | +2988.36% |
| Q1 2021 | 2021-03-31 | $9.1M | $8.2M | +843.08% |
| Q4 2020 | 2020-12-31 | $45.3M | — | — |
| Q3 2020 | 2020-09-30 | $4.3M | — | — |
| Q2 2020 | 2020-06-30 | $275,000 | — | — |
| Q1 2020 | 2020-03-31 | $968,000 | — | — |
Instil Bio capital expenditures (capex) trends
Over the last five fiscal years, Instil Bio's capital expenditures (capex) decreased from $50.8M to $10.0M, a change of −$40.8M. The latest reported quarter, Q4 2024, shows $0.
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Instil Bio source filings ↗